X

Closed projects

Since its creation, the department ovo r&d has already completed many research projects. Here is the list as well as some characteristics about each of these projects.

  • Académie

  • Demande d’information (Accueil)

    Fields marked with an * are required
    Formulaire de questions

    *mentions obligatoires

  • Fields marked with an * are required
    Question form
    *mandatory information
  • Discover the ovo clinic

  • Contact us

    Contact us

    clinique ovo montreal

    All services offered 8000, boul. Décarie,
    Montreal Qc H4P 2S4
    ovo fertility office 100 & 200
    Monday to Friday 7:30am to 6:00pm
    Weekend on appointment
    fertilite@cliniqueovo.com
    ovo elle bureau 600
    Monday to Friday 8:00am to 4:00pm
    elle@cliniqueovo.com
    ovo cryo Monday to Wed. 8:00am to 5:00pm
    Thursday 8:00am to 6:00pm
    Friday 8:00am to 5:00pm
    Saturday 9:00am to 3:00pm
    Appointments :
    Monday to Friday 9:00am to 3:00pm
    Thursday 9:00am to 4:00pm
    Saturday 9:00am to 2:30pm
    cryo@cliniqueovo.com
    ovo biosurance office 600
    Monday to Friday 8:00am to 4:00pm
    biosurance@cliniqueovo.com
    ovo labo office 600
    Monday to Friday 8:00am to 4:00pm
    labo@cliniqueovo.com
    ovo prenatal office 600
    Monday to Friday 8:00am to 4:00pm
    prenatal@cliniqueovo.com
    ovo r&d office 600
    Monday to Friday 7:15am to 5:00pm
    r-d@cliniqueovo.com

    clinique ovo rive-sud

    3141, boul. Taschereau,
    Greenfield Park Qc J4V 2H2
    ovo fertility - certain services offered office 410
    Call to know our hours
    fertilite@cliniqueovo.com
    ovo prenatal - certain services offered office 420
    Monday to Friday 8:00am to 4:00pm
    prenatal@cliniqueovo.com
    ovo labo - certain services offered office 420
    Monday to Friday 8:00am to 4:00pm
    labo@cliniqueovo.com

    clinique ovo quebec

    ovo prenatal - certain services offered 2600 Boul. Laurier, suite 295,
    Quebec Qc G1V 4T3
    Monday to Friday 8:00am to 4:00pm prenatal@cliniqueovo.com



    clinique ovo rive-nord

    ovo prenatal - Prenatal screening 1000 Montée des Pionniers,
    Terrebonne QC J6V 1S8
    Monday to Thursday 9:00am to 3:00pm
    prenatal@cliniqueovo.com

    clinique Echo-medic

    Ovo prenatal - certain services
    Laval 1575, boul. de l'Avenir, suite 110,
    Laval Qc H7S 2N5
    t. 1.877.664.3246
    Monday to Thursday 7:30am to 4:30pm
    Friday 7:30am to 3:00pm
    Boisbriand 20865, chemin de la Côte Nord, suite 201
    Boisbriand Qc J7E 4H5
    t. 1.877.664.3246
    Monday to Thursday 8:00am to 4:00pm
    Friday 8:00am to 3:00pm
    Montreal and South-Shore: t. 514.798.2000
    Quebec: t. 418.425.0128
    f. 514.798.2001
  • Make an appointment

Research projects Sponsor Number of participants
In Vitro Fertilization
OVOGEN: A randomized, double-blind, trial evaluating autologous endometrial co-culture (AECC) vs conventional medium in the treatment of fertility.
450-600: Effect of a Higher than Maximum 450IU Gonadotropin Dose on Patient Outcome in an IVF Setting : A Randomized Controlled Non-Inferiority Trial. 366
Chronic Endometritis : Phase I:
Prevalence of chronic endometritis in Patients with Recurrent Miscarriages or Repeated Implantation Failures in In-Vitro Fertilization.
100
G-test : Validation of the procedure 68
Doppler : Perifollicular Doppler in natural cycle IVF 160
PEPI : Pilot Study in order to Examine the Ultrasound Parameters Predictive of Implantation 387
Marvelon vs Nuvaring : Effects of using NuvaRing on coordinating IVF cycles and on the level of satisfaction and stress on users: randomized public study 8
Basic : A randomised, placebo-controlled, double-blind, parallel groups, multinational, multicenter trial assessing the effect of Barusiban administered subcutaneously on the day of transfer on implantation and pregnancy rates in IVF/ICSI patients. 18
Implant : A phase 3, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of a single oral administration of nolasiban to increase on-going pregnancy rate following fresh single blastocyst transfer resulting from IVF. 21
E4 Freedom : A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15mg Estetrol and 3mg Drospirenone. 10
Follicular fluid : Comparative study of non-esterified fatty acid concentrations in follicular fluid in women with and without polycystic ovarian syndrome during an in vitro fertilization protocol. 7
Endometriose
Esparios :Étude multicentrique de phase IIb à répartition aléatoire, en groupes parallèles, à double insu et à double placebo visant à évaluer pendant une période de traitement de 12 semaines l’efficacité et l’innocuité de différentes associations de doses d’un inhibiteur de l’aromatase et d’un progestatif contenues dans un anneau vaginal, par rapport à un placebo et à la leuproréline/l’acétate de leuprolide, chez des femmes atteintes d’endométriose symptomatique. 4
Violet petal study : A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe endometriosis-associated pain. 2
VIOLET PETAL STUDY EXTENTION : Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain. 1
Fibromes
Fibromyomes utérins M12-813 : A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids. 4
Insemination
LH URINAIRE : Combining urinary luteinizing hormone testing with ultrasound monitoring in intra uterine insemination cycles.
Crinone : Observational study evaluating the use of intravaginal Crinone for luteal support in intrauterine insemination with gonadotropins 40
Prenatal Screening
PlGF: Prospective study in order to evaluate the benefits of 1st trimester risk markers in detecting early onset preeclampsia and the use of Placental Growth Factor (PlGF) as a potential marker for trisomy 21 and other aneuploidies.
Stems cells
MSC : Evaluation of the isolation and proliferation potential of the mesenchymal stem cells contained in the “waste” portion of a cord blood sample. 22
Other
FERRING LUTREPULSE OMNIPOD: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism.
AMH: Multi-Center Clinical evaluation if the Access AMH Assay to measure AMH as an aid in the prediction of poor ovarian response to controlled ovarian stimulation.
IRNPQ : Integrated Research Network in Perinatalogy of Quebec and Eastern Ontario 3
PCR digital : Screening for chromosomal abnormalities on fetal cells. 276
Projet experience couple´: Dyadic and dynamic co- construction of meaning from the experience of fertility treatments among heterosexual couples. 3
Second part of the development of a test to evaluate the receptivity and tolerance of the endometrium for the embryo : Personalized Molecular Test Based on the Receptivity of the Endometrium and the Maternal-Embryonic Cross-Talk.